Arie Belldegrun - Net Worth and Insider Trading
Arie Belldegrun Net Worth
The estimated net worth of Arie Belldegrun is at least $626 Million dollars as of 2024-11-05. Arie Belldegrun is the Chairman, President and CEO of Kite Pharma Inc and owns about 3,306,429 shares of Kite Pharma Inc (KITE) stock worth over $594 Million. Arie Belldegrun is the Director of Allogene Therapeutics Inc and owns about 10,639,146 shares of Allogene Therapeutics Inc (ALLO) stock worth over $31 Million. Arie Belldegrun is also the Director of Arno Therapeutics Inc and owns about 3,218,577 shares of Arno Therapeutics Inc (ARNI) stock worth over $322. Details can be seen in Arie Belldegrun's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arie Belldegrun has not made any transactions after 2024-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Arie Belldegrun
Arie Belldegrun Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arie Belldegrun owns 7 companies in total, including Kronos Bio Inc (KRON) , UroGen Pharma Ltd (URGN) , and Allogene Therapeutics Inc (ALLO) among others .
Click here to see the complete history of Arie Belldegrun’s form 4 insider trades.
Insider Ownership Summary of Arie Belldegrun
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KRON | Kronos Bio Inc | 2020-10-08 | director & 10 percent owner |
| URGN | UroGen Pharma Ltd | 2019-01-01 | director |
| ALLO | Allogene Therapeutics Inc | 2024-05-16 | director & 10 percent owner |
 | | 2017-09-25 | director & Chairman & President and CEO |
| | 2016-08-15 | director |
| | 2009-09-24 | director |
| | 2021-09-16 | director |
Arie Belldegrun Latest Holdings Summary
Arie Belldegrun currently owns a total of 3 stocks. Among these stocks, Arie Belldegrun owns 3,306,429 shares of Kite Pharma Inc (KITE) as of September 25, 2017, with a value of $594 Million and a weighting of 95%. Arie Belldegrun owns 10,639,146 shares of Allogene Therapeutics Inc (ALLO) as of May 16, 2024, with a value of $31 Million and a weighting of 5%. Arie Belldegrun also owns 3,218,577 shares of Arno Therapeutics Inc (ARNI) as of January 12, 2016, with a value of $322 and a weighting of 0%.
Latest Holdings of Arie Belldegrun
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KITE | Kite Pharma Inc | 2017-09-25 | 3,306,429 | 179.79 | 594,462,870 |
| ALLO | Allogene Therapeutics Inc | 2024-05-16 | 10,639,146 | 2.94 | 31,279,089 |
| ARNI | Arno Therapeutics Inc | 2016-01-12 | 3,218,577 | 0.00 | 322 |
Holding Weightings of Arie Belldegrun
Arie Belldegrun Form 4 Trading Tracker
According to the SEC Form 4 filings, Arie Belldegrun has made a total of 0 transactions in Kite Pharma Inc (KITE) over the past 5 years. The most-recent trade in Kite Pharma Inc is the sale of 26,347 shares on September 25, 2017, which brought Arie Belldegrun around $5 Million.
According to the SEC Form 4 filings, Arie Belldegrun has made a total of 3 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Allogene Therapeutics Inc is the acquisition of 1,724,137 shares on May 16, 2024, which cost Arie Belldegrun around $5 Million.
According to the SEC Form 4 filings, Arie Belldegrun has made a total of 0 transactions in Arno Therapeutics Inc (ARNI) over the past 5 years. The most-recent trade in Arno Therapeutics Inc is the acquisition of 2,162,347 shares on January 12, 2016, which cost Arie Belldegrun around $756,821.
Insider Trading History of Arie Belldegrun
- 1
Arie Belldegrun Trading Performance
GuruFocus tracks the stock performance after each of Arie Belldegrun's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arie Belldegrun is 4.34%. GuruFocus also compares Arie Belldegrun's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arie Belldegrun within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arie Belldegrun's insider trading performs compared to the benchmark.
Performance of Arie Belldegrun
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.31 | | | | | |
| Relative Return to S&P 500(%) | 4.35 | | | | | |
Arie Belldegrun Ownership Network
Ownership Network List of Arie Belldegrun
Ownership Network Relation of Arie Belldegrun
Arie Belldegrun Owned Company Details
What does Kronos Bio Inc do?
Who are the key executives at Kronos Bio Inc?
Arie Belldegrun is the director & 10 percent owner of Kronos Bio Inc. Other key executives at Kronos Bio Inc include director & 10 percent owner & President & CEO Norbert W Bischofberger , COO & General Counsel Barbara Kosacz , and Chief Scientific Officer Christopher Dinsmore .
Kronos Bio Inc (KRON) Insider Trades Summary
Over the past 18 months, Arie Belldegrun made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net purchase of 5,351,696 shares made by Norbert W Bischofberger , a net sale of 40,194 shares made by Jorge Dimartino , and a net sale of 24,032 shares made by Christopher Dinsmore .
In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,028 shares of Kronos Bio Inc (KRON) were sold and 5,351,696 shares were bought by its insiders, resulting in a net purchase of 5,235,668 shares.
Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kronos Bio Inc Insider Transactions
Arie Belldegrun Mailing Address
Above is the net worth, insider trading, and ownership report for Arie Belldegrun. You might contact Arie Belldegrun via mailing address: Ucla School Of Medicine, 10833 Le Conte 66-118 Chs Box 951738, Los Angeles Ca 9095-1738.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
